Subscribe to RSS
DOI: 10.1055/s-0031-1286105
© Georg Thieme Verlag KG Stuttgart · New York
Diagnostik- und Therapiestrategien beim Barrett-Ösophagus
Diagnostic and therapeutic management of Barrett’s esophagusPublication History
eingereicht: 15.5.2011
akzeptiert: 18.8.2011
Publication Date:
31 August 2011 (online)

Zusammenfassung
Der Barrett-Ösophagus (BE) gilt als Folgeerscheinung einer chronischen gastroösophagealen Refluxerkrankung und geht mit dem erhöhten Risiko eines Adenokarzinoms einher. Die Diagnose besteht aus der endoskopischen Darstellung eines veränderten Epithels im distalen Ösophagus und dem histologischen Nachweis einer intestinalen Metaplasie vom spezialisierten Typ. Beim Nachweis eines BE muss eine leitliniengerechte Überwachung stattfinden, die Intervalle richten sich zur Zeit nach der Länge des BE und dem Grad der intraepithelialen Neoplasie (IEN). Zur besseren Detektion von IEN kommen verschiedene Techniken zum Einsatz. Durchgesetzt hat sich die hochauflösende Videoendoskopie. Beim Nachweis hochgradiger Dysplasien ist eine Therapie erforderlich; zur Verfügung stehen endoskopisch-ablative und -resektive Verfahren. Auch mukosale Karzinome können endoskopisch reseziert werden, ab einer Infiltrationstiefe bis in die Submukosa (T1b) ist eine Operation indiziert.
Schlüsselwörter
Barrett-Ösophagus - gastroösophagealen Refluxerkrankung - intestinalen Metaplasie
Keywords
Barrett’s esophagus - gastroesophageal reflux disease - intestinal metaplasia
Literatur
- 1
American Gastroenterological
Association .
American Gastroenterological Association
Medical Position Statement on the Management of Barrett’s Esophagus.
Gastroenterology.
2011;
140
1084-1091
MissingFormLabel
- 2
Badreddine R, Wang K, Ganapathy A. et al .
Confocal laser microscopy guided endoscopic
mucosal resection in Barrett’s esophagus with high-grade
dysplasia.
Gastrointest Endosc.
2008;
67
179
MissingFormLabel
- 3
Behrens A, Pech O, Graupe F. et
al .
Barrett-Karzinom der Speiseröhre.
Dtsch Arztebl
Int.
2011;
108
313-319
MissingFormLabel
- 4
Cijs T M, Verhoef C, Steyerberg E W. et al .
Outcome of esophagectomy
for cancer in elderly patients.
Ann Thorac Surg.
2010;
90
900-907
MissingFormLabel
- 5
Collard, JM.
High-grade-dysplasia in Barrett’s esophagus. The case
for esophagectomy.
Chest Surg Clin N Am.
2002;
12
77-92
MissingFormLabel
- 6
Curvers W L, ten Kate F J, Krishnadath K K. et al .
Low grade dysplasie
in Barrett’s esophagus: overdiagnosed and underestimated.
Am J Gastroenterol.
2010;
105
1523-1530
MissingFormLabel
- 7
Curvers W L, van Vilsteren F G, Baak L C. et al .
Endoscopic trimodal
imaging versus standard video endoscopy for detection of early Barrett’s
neoplasia: a multicenter, randomized, crossover study in general
practice.
Gastrointest Endosc.
2011;
73
195-203
MissingFormLabel
- 8
De Jonge P JF, van Blankenstein M, Looman C WN. et al .
Risk of malignant progression
in Patients with Barrett’s esophagus: a Dutch nationwide
cohort study.
Gut.
2010;
59
1030-1036
MissingFormLabel
- 9
Ell C, May A, Gossner L. et
al .
Endoscopic mucosal resection of early cancer and
high-grade dysplasia in Barrett’s esophagus.
Gastroenterology.
2000;
118
670-677
MissingFormLabel
- 10
Eloubeidi M A, Provenzeale D.
Does this patient
have Barrett’s esophagus- the need for standardization
of the definition and of endoscopic criteria.
Am J Gastroenterol.
1998;
93
1033-1036
MissingFormLabel
- 11
Gerson L B, Shetler K, Triadafilopoulos G.
Prevalence of Barrett’s eosophagus in asymptomatic
individuals.
Gastroenterology.
2002;
123
668-671
MissingFormLabel
- 12
Hartmann D, Kudis V, Jakobs R, Riemann J F, Schilling D.
Course of erosive gastroesophageal reflux disease (ERD) under
therapeutic daily life conditions. A prospective examination with
a mean follow up of 6.5 years.
Z Gastroenterol.
2006;
44
1039-1042
MissingFormLabel
- 13
Horwhat J D, Baroni D, Maydonovitch C. et al .
Normalization of intestinal metaplasia
in the esophagus and esophagogastric junction: incidence and clinical
data.
Am J Gastroenterol.
2007;
102
497-506
MissingFormLabel
- 14
Kara M A, Peters F P, Fockens P. et al .
Endoscopic video-autofluorenscence imaging
followed by narrow band imaging for dedection early neoplasia in
Barrett’s esophagus.
Gastrointest Endosc.
2006;
64
176-185
MissingFormLabel
- 15
Konda V J, Ross A S, Ferguson M K. et al .
Is the risk of concomitant
invasive esophageal cnacer in high-grade.dysplasie in Barrett’s
esophagus overestimated?.
Clin Gastroenterol Hepatol.
2008;
6
159-164
MissingFormLabel
- 16
Lagergren J, Bergstrom R, Lindgren A. et al .
Symptomatic gastroesophageal reflux as
a risk factor for esophageal adenocarcinoma.
N Engl J
Med.
1999;
340
824-831
MissingFormLabel
- 17
Mannath J, Subramanian V, Hawkey C J, Ragunath K.
Narrow
band imaging for characterization of high grade dysplasia and specialized
intestinal metaplasia in Barrett’s esophagus: a meta-analysis.
Endoscopy.
2010;
42
351-359
MissingFormLabel
- 18
Messmann H, Ell C, Fein M. et
al .
Gastroösophageale Refluxerkrankung – Ergebnisse
einer evidenzbasierten Konsensuskonferenz der DGVS. Themenkomplex
VI: Barrett-Ösophagus.
Z Gastroenterol.
2005;
43
165-194
MissingFormLabel
- 19
Ngamruengphong S, Sharma V K, Das A.
Diagnostic yiled of methylene blue chromoendoscopy for detecting
specialized intestinal metaplasia and dysplasia in Barrett’s
esophagus: a meta-analysis.
Gastrointest Endosc.
2009;
69
1021-1028
MissingFormLabel
- 20
Ormsby A H, Kilgore S P.
The location
and frequency of intestinal metaplasia at the esophagogastric junction
in 223 consecutive autopsies: implications for patient treatment
and preventive strategies in Barrett’s esophagus.
Mod
Pathol.
2000;
13
614-620
MissingFormLabel
- 21
Pech O, Behrens A, May A. et
al .
Long term results and risk factors analysis for
recurrence after curative endoscopic therapy in 349 patients with high-grade
intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s
oesophagus.
Gut.
2008;
57
1200-1206
MissingFormLabel
- 22
Pohl H, Rösch T, Vieth M. et al .
Miniprobe confocal laser microscopy for
the detection of invisable neoplasia in Patients with Barrett’s
esophagus.
Gut.
2008;
57
1648-1653
MissingFormLabel
- 23
Pohl J, Pech O, May A. et
al .
Incidence of macroscopically occult neoplasias in
Barrett’ esophagus: a random biopsies dispensable in agree
of advanced endoscopic imaging?.
Am J Gastroenterol.
2010;
105
2350-2356
MissingFormLabel
- 24
Riddell R H, Odze R D.
Definition of
Barett’s esophagus: time for rethink – is intestinal
metaplasia dead?.
Am J Gastroenterol.
2009;
14
2588-2594
MissingFormLabel
- 25
Shaheen N J, Greenwald B D, Peery A F. et al .
Safty and efficacy of endoscopic spray
cryotherapy for Barrett’s esophagus with high-grade dysplasia.
Gastrointest Endosc.
2010;
71
680-685
MissingFormLabel
- 26
Shaheen N J, Sharma P, Overholt B F. et al .
Radiofrequency ablation in Barrett’s
esophagus with dysplasia.
N Engl J Med.
2009;
360
2277-2288
MissingFormLabel
- 27
Sharma V K, Wang K K, Overholt B F. et al .
Ballon-based, circumferential,
endoscopic radiofrequency ablation of Barrett’s esophagus:
1-year follow up of 100 patients.
Gastrointst Endosc.
2007;
65
185-194
MissingFormLabel
- 28
Skacel M, Petras R E, Gramlich T L. et al .
The diagnose of low-grade
dysplasie in Barrett’s esophagus and its implication for
disease progression.
Am J Gastroenterology.
2000;
95
3383-3387
MissingFormLabel
- 29 Spechler S J, Talley N, Travis A. Management of Barrett’s esophagus. http://www.uptodate.com/contents (letzter Zugriff 11.8.2011)
MissingFormLabel
- 30
Spechler S J.
Clinical practice. Barrett’s esophagus.
N
Engl J Med.
2002;
346
836-842
MissingFormLabel
- 31
Van Vilsteren F G, Pouw R E, Seewald S. et al .
Stepwise radical endoscopic
resection versus radiofrequency ablation for Barrett’s
oesophagus with high-grade dysplasia or early cancer: a multicentre
randomized trial.
Gut.
2011;
60
765-773
MissingFormLabel
- 32
Wallace M B, Sharma P, Lightdale C. et al .
Preliminary accurancy and interobserver
agreement for the detection of intraepithelial neoplasia in Barrett’s
oesophagus with probe-based confocal laser endomicroscopy.
Gastrointest
Endosc.
2010;
72
19-24
MissingFormLabel
- 33
Wani S B, Falk G W, Hall M. et al .
Low risk of developing dysplasia and esophageal
adenocarinoma (EAC) in patients with non-dysplastic Barrett’s esophagus
(BE): results from a large, multicenter, cohort study.
Gastroenterology.
2010;
138
S63
MissingFormLabel
- 34
Weston A P, Krmpotich P T, Cherian R. et al .
Prospective long term endoscopic and histological
follow up of short segment Barrett’s esophagus: comparison
with traditional long segment Barrett’s esophagus.
Am
J Gastroenterol.
1997;
92
407-413
MissingFormLabel
- 35
Wolfsen H C, Crook J E, Krishna M. et al .
Prospective, controlled tandem endoskopy
study of narrow band imaging for dysplasia detection in Barrett’s
esophagus.
Gastroenterology.
2008;
135
24-31
MissingFormLabel
- 36
Yousef F, Cardwell C. et al .
The
incidence of esophageal cancer and high-grade dysplasia in Barrett’s
esophagus: a systematic review and metaanalysis.
Am J
Epidemiol.
2008;
168
237-249
MissingFormLabel
Dr. med. Daniela Müller-Gerbes
Medizinische Klinik
Krankenhaus Holweide
Kliniken
der Stadt Köln gGmbH
Neufelder Str. 32
51069
Köln
Phone: 0221/8907-12606
Fax: 0221/8907-2799
Email: muellergerbd@kliniken-koeln.de